Prostate Cancer: 2021 ASCO Annual Meeting Highlights for the Advanced Practitioner
Morgane C. Diven, PharmD, BCOP
Phoenix VA Health Care System
J Adv Pract Oncol 2021;12(6):609-614 |
© 2021 Harborside™
Morgane C. Diven, PharmD, BCOP, of Phoenix VA Health Care System, evaluates research on an investigational radiolabeled small molecule, combination therapy in the treatment of de novo metastatic prostate cancer, and a CYP17-lyase inhibitor in metastatic hormone-sensitive prostate cancer. Coverage provided by The ASCO Post.
For access to the full length article, please sign in